Sleep-inducing effects mediated by a selective orexin-2 receptor antagonist during the light phase in the rat

被引：0
|
作者：
Shelton, J. [1 ]
Sutton, S. [1 ]
Yun, S. [1 ]
Li, S. [1 ]
Dvorak, C. [1 ]
Carruthers, N. [1 ]
Lovenberg, T. [1 ]
Dugovic, C. [1 ]
机构：
[1] Johnson & Johnson PRDUS LLC, San Diego, CA USA
来源：
JOURNAL OF SLEEP RESEARCH | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [21] The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
    Kasper Recourt
    Peter de Boer
    Rob Zuiker
    Remy Luthringer
    Justine Kent
    Peter van der Ark
    Ilse Van Hove
    Joop van Gerven
    Gabriel Jacobs
    Luc van Nueten
    Wayne Drevets
    Translational Psychiatry, 9
  • [22] Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
    Sun, Hong
    Palcza, John
    Rosenberg, Russell
    Kryger, Meir
    Siringhaus, Tara
    Rowe, Janice
    Lines, Christopher
    Wagner, John A.
    Troyer, Matthew D.
    RESPIRATORY MEDICINE, 2015, 109 (03) : 416 - 426
  • [23] Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
    Kasper Recourt
    Peter de Boer
    Rob Zuiker
    Remy Luthringer
    Justine Kent
    Peter van der Ark
    Ilse Van Hove
    Joop van Gerven
    Gabriel Jacobs
    Luc van Nueten
    Wayne Drevets
    Translational Psychiatry, 9
  • [24] The effects of delta sleep-inducing peptide on the intensity of lipid peroxidation and xanthine oxidase activity in rat tissues during cold stress
    Bondarenko T.I.
    Milyutina N.P.
    Shustanova T.A.
    Mikhaleva I.I.
    Neuroscience and Behavioral Physiology, 2001, 31 (1) : 83 - 86
  • [25] N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline:: The first orexin-2 receptor selective non-peptidic antagonist
    Hirose, M
    Egashira, S
    Goto, Y
    Hashihayata, T
    Ohtake, N
    Iwaasa, H
    Hata, M
    Fukami, T
    Kanatani, A
    Yamada, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) : 4497 - 4499
  • [26] Differences in the in vivo and in vitro effects of the endogenous sleep-inducing agent oleamide on 5-HT2 receptor function
    Cadogan, AK
    Fletcher, C
    de Bank, P
    Marsden, CA
    Kendall, DA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U143 - U143
  • [27] Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats
    Brotschi, Christine
    Bolli, Martin H.
    Gatfield, John
    Roch, Catherine
    Sifferlen, Thierry
    Treiber, Alexander
    Williams, Jodi T.
    Boss, Christoph
    RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 344 - 354
  • [28] Effects of selective glutamate mGlu5 receptor antagonist, MPEP, on sleep and wakefulness in the rat
    Scesa, G. L.
    Cavas, M.
    Navarro, J. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S239 - S239
  • [29] The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
    Brooks, Sander
    Jacobs, Gabriel E.
    de Boer, Peter
    Kent, Justine M.
    Van Nueten, Luc
    van Amerongen, Guido
    Zuiker, Rob
    Kezic, Iva
    Luthringer, Remy
    van der Ark, Peter
    van Gerven, Joop M. A.
    Drevets, Wayne
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (02) : 202 - 209
  • [30] Dual Orexin Receptor Antagonist E2006 Shows Efficacy on Sleep Initiation and Maintenance in Phase 2 Study
    Satlin, Andrew
    Murphy, Patricia
    Moline, Margaret
    Orford, Colin
    Giorgi, Luigi
    Bradshaw, Kate
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S336 - S337
12345